Takeda Pharmaceutical TAK
Ownership & positioning
Who holds it, who is betting against it, and where the big money is moving
Short-sale volume as % of daily volume
Large-order net flow, last 20 sessions
Net of large-order buying minus selling, in USD. Over this window: +$1.16M (14 inflow days, 6 outflow days).
Net flow by order size, last 20 sessions
Super/Big orders approximate institutional-size trades; Mid/Small approximate retail-size trades. Net buy minus sell value in each bucket, summed over the window.
The five largest holders on file together own 23.6% of shares outstanding.
Largest holders
By investor type
Reported short interest has held roughly steady near 0.10% of float over the last 6 biweekly reports (14 Aug 2026 to 30 Oct 2026).
Recent institutional activity
| Holder | Type | Period | Share change | New stake |
|---|---|---|---|---|
| Global X Japan Co. Ltd. | Mutual Fund | 2026/Q3 | +1,319,474 | 0.1% |
| Capital Research | Mutual Fund | 2026/Q3 | +2,380,130 | 3.0% |
| Amundi Asset Management | Mutual Fund | 2026/Q3 | +875,922 | 0.4% |
| BlackRock | Mutual Fund | 2026/Q3 | +20,502,452 | 9.1% |
| Charles Schwab Investment Management | Mutual Fund | 2026/Q3 | +848,164 | 0.5% |
| Barclays PLC | Public Company | 2026/Q3 | +35,063,130 | 0.0% |
| Capital Research | Mutual Fund | 2026/Q3 | +6,318,200 | 3.1% |
| Strategic Advisers LLC | Mutual Fund | 2026/Q3 | +4,202,114 | 0.8% |
| J.P. Morgan Asset Management, Inc. | Mutual Fund | 2026/Q3 | +3,377,462 | 0.7% |
| Vanguard Capital Management, LLC | Mutual Fund | 2026/Q3 | +2,385,044 | 3.9% |
| Nomura Asset Management | Mutual Fund | 2026/Q3 | +1,276,800 | 4.5% |
| Morgan Stanley | Public Company | 2026/Q3 | +1,239,470 | 0.3% |
| Vanguard Asset Management, Limited | Mutual Fund | 2026/Q3 | +890,118 | 0.4% |
| BlackRock | Mutual Fund | 2026/Q3 | +20,379,712 | 9.1% |
| Vanguard Capital Management, LLC | Mutual Fund | 2026/Q3 | +774,000 | 3.9% |
Institutional buy/sell activity by reporting period, largest moves first.
Insider transactions
| Date | Insider | Title | Transaction | Shares | Price | Held after |
|---|---|---|---|---|---|---|
| 3 Nov 2026 | Giles Platford | President of International Business Unit | Open Market Disposition | -55,617 | $20.90 | 170,713 |
| 1 Nov 2026 | Teresa Marie Bitetti | President of the Global Oncology Business Unit | Private Disposition | -46,609 | $0.13 | 124,869 |
| 31 Oct 2026 | Giles Platford | President of International Business Unit | Intent to Sell (Form 144) | -55,617 | $20.17 | – |
| 13 Sep 2026 | Lauren Duprey | Chief Transformation Officer | Open Market Disposition | -34,535 | $18.54 | 100,278 |
| 1 Sep 2026 | Andrew S. Plump | President of Research & Development and Representative Director | Automatic Disposition | -116,191 | $18.49 | 651,690 |
| 18 Aug 2026 | Andrew S. Plump | President of Research & Development and Representative Director | Automatic Disposition | -19,651 | $18.49 | 767,881 |
| 17 Aug 2026 | Nicola Greenway | Open Market Disposition | -12,980 | $18.11 | – | |
| 13 Aug 2026 | Nicola Greenway | Intent to Sell (Form 144) | -12,980 | $17.39 | – | |
| 10 Aug 2026 | Elaine Shannon | President of Global Supply & Quality | Open Market Disposition | -20,363 | $17.55 | 19,237 |
| 9 Aug 2026 | Andrew S. Plump | President of Research & Development and Representative Director | Private Disposition | -165,393 | $17.10 | 787,532 |
| 9 Aug 2026 | Giles Platford | President of International Business Unit | Private Disposition | -31,083 | $17.10 | 216,298 |
| 9 Aug 2026 | Farajallah Awny Botros | Chief Medical Officer | Private Disposition | -14,006 | $17.10 | 61,965 |
| 9 Aug 2026 | Julie Kim | Chief Executive Officer | Private Disposition | -89,090 | $17.10 | 260,209 |
| 9 Aug 2026 | Teresa Marie Bitetti | President of the Global Oncology Business Unit | Private Disposition | -50,012 | $17.10 | 162,378 |
| 9 Aug 2026 | Ramy Ibrahim | Private Disposition | -7,277 | $17.10 | 52,604 | |
| 9 Aug 2026 | Lauren Duprey | Chief Transformation Officer | Private Disposition | -47,586 | $17.10 | 134,813 |
| 9 Aug 2026 | Gabriele Ricci | Chief Data & Technology Officer | Private Disposition | -25,088 | $17.10 | 110,216 |
| 9 Aug 2026 | Marcello Pignagnoli Agosti | Interim Head of Strategy & Portfolio Development | Private Disposition | -22,957 | $17.10 | 120,051 |
| 9 Aug 2026 | Elaine Shannon | President of Global Supply & Quality | Private Disposition | -3,978 | $17.10 | 19,237 |
| 9 Aug 2026 | Natalie Furney | Global General Counsel | Private Disposition | -30,868 | $17.10 | 32,890 |
From Form 4/Form 144 filings. Negative share counts are disposals (sales, gifts, or shares withheld for taxes); positive are acquisitions.
Short interest, by report
| Report date | Shares short | % of float | Days to cover |
|---|---|---|---|
| 30 Oct 2026 | 3,066,552 | 0.1% | 1.0 |
| 15 Oct 2026 | 3,289,262 | 0.1% | 1.1 |
| 30 Sep 2026 | 2,918,812 | 0.1% | 1.2 |
| 15 Sep 2026 | 4,204,915 | 0.1% | 2.0 |
| 31 Aug 2026 | 4,088,761 | 0.1% | 1.8 |
| 14 Aug 2026 | 2,992,883 | 0.1% | 1.0 |
No comments yet — be the first to weigh in on TAK.
Sign in to join the discussion.